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Listeria monocytogenes causes listeriosis and is one of the most virulent foodborne pathogens.
Different subtyping techniques classified L. monocytogenes into four genetic lineages (I, II, III
and IV) and seventeen serotypes. Most outbreaks of listeriosis are caused by lineage I. Lineage II
is mostly associated with sporadic listeriosis, while Lineage III strains are typically lower risk for
causing listeriosis. Listeriosis mainly affects elderly, immunosuppressed, children, and pregnant
women causing fetal death, miscarriage, meningitis, encephalitis, and septicemia. Therefore, it is
important to differentiate high-risk strains from low-risk strains, which will permit early and
appropriate interventions. Our main goal in this current work is to detect candidate biomarkers
unique to lineage III strains that can be used to differentiate lineage III strains from lineage I and
II. To achieve this goal, mass spectrometry, bioinformatics, and comparative proteomics were
applied to detect biomarkers unique to lineage III strains.
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CHAPTER I
LITERATURE REVIEW
Listeria monocytogenes
Listeria monocytogenes was first reported by E.G.D. Murray in 1924 based on six cases
of sudden death in young rabbits (Murray et al., 1926). Murray named the bacteria Bacterium
monocytogenes. Later, Harvey Pirie changed the genus name to Listeria in 1940.
Listeria was not known as a food-borne pathogen until the end of the 1970s and early
1980s (Schlech et al., 1983). Listeriosis was first reported in Halifax, Nova Scotia, involving 41
cases and 18 deaths, mostly in pregnant women and neonates. It was epidemiologically linked to
the consumption of coleslaw that had been produced from cabbage contaminated with L.
monocytogenes contaminated sheep manure. Since then, several cases of listeriosis have been
reported and estimated to reach 3000 case each year from foodborne illness so, L.
monocytogenes is now widely recognized as an important hazard in the food industry (Ryser and
Marth, 1999).
Microbiology of Listeria monocytogenes
Listeria monocytogenes is a small rod-shaped bacterium, facultatively anaerobic, and
non-spore forming (Gray and Killinger, 1966). Listeria monocytogenes is catalase-positive and
oxidase-negative. Listeria grows on blood agar and expresses incomplete β-hemolysis destroys
red blood cells. The genus Listeria is a member of the class Bacilli and the order Bacillales,
which also includes Bacillus and Staphylococcus (Sallen et al., 1996).
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Optimal growth for Listeria species is between 30°C to 37°C, but, unlike most bacteria,
L. monocytogenes can grow at a permissive range of growth temperature from -1C - 45C,
making it a psychrotroph and a mesophile (Junttila et al., 1988). The bacterium at 20-25C
expresses peritrichous flagella and is motile, whereas at 37C it is weakly motile or non-motile
(Galsworthy et al., 1990).
Listeria monocytogenes and other Listeria species have been reported in at least 37
mammalian species. The most important reservoirs are ruminants (Gray and Killinger, 1966).
Listeria is also found in at least 17 species of birds that can serve as a reservoir and can
contaminate surrounding environments (Dhama et al., 2013; Kurazono et al., 2003). L.
monocytogenes also can be harbored by some species of fish and shellfish (ESTELA et al.,
1992).
Listeria monocytogenes is widely distributed in the environment including soil, silage,
water, and other environmental sources. Listeria monocytogenes is stable and can resist the
deleterious effects of freezing, drying, and heat (Nightingale et al., 2004). It can survive in feces
up to 347 days at ambient temperatures and for 27 days in 12% NaCl (Stelma and McCabe,
1992). Since L. monocytogenes is so widespread in the environment and livestock, it is not
surprising that it is frequently found in vegetables and grass (Fenlon et al., 1996). However,
contaminated agricultural environments and products rarely appear to directly cause human
infection (Nightingale et al., 2004),
Listeria monocytogenes can persist in food-processing environments. It can tolerate low
pH, high sodium concentrations, and worst of all, survive near freezing temperature (2-4°C)
(Gandhi and Chikindas, 2007a; Gandhi and Chikindas, 2007b). It can also grow over a wide
range of pH (4.3-9.6), water activity (aw) less than .93 (Farber and Coates, 1992). and salt
2

concentrations (up to 10%) (Seeliger and Höhne, 1979). This makes Listeria monocytogenes a
serious threat to food safety and the food industry (Vazquez-Boland et al., 2001).
The foods that are usually implicated for transmission of L. monocytogenes infection are
soft cheeses, dairy products, raw milk, pasteurized fluid milk, cheeses (particularly soft-ripened
varieties), ice cream, raw vegetables, fermented raw-meat sausages, raw and cooked poultry, raw
meats (of all types), raw and smoked fish, and refrigerated ready-to-eat products that are eaten
without reheating (Farber and Peterkin, 1991; Wilesmith and Gitter, 1986). In
animals, Listeria monocytogenes infection is transmitted by feeding of spoiled silage, in which
the bacteria widely multiply (Vazquez-Boland et al., 1992).
Listeria genus
Initially, genus Listeria was classified in the family of Corynebacteriaceae. In 2004, the
genus was moved to the newly created family Listeriaceae based on 16S rRNA sequencing
(Somer and Kashi, 2003). For many years the genus Listeria only contained one species, L.
monocytogenes. Currently, genus Listeria has seventeen species including L. monocytogenes, L.
fleischmannii, L. grayi, L. innocua, L. ivanovii, L. marthii, L. monocytogenes, L. rocourtiae, L.
seeligeri, L. weihenstephanensis and L. welshimeri. L. denitrificans (Collins et al., 1991;
Rocourt, 1999; Vázquez-Boland et al., 2001). At present only L. monocytogenes is known to be
pathogenic to humans and animals, while L. ivanovii is pathogenic only in animals, particularly
ruminants (Gouin et al., 1994).
Classification of Listeria monocytogenes
Based on genomic content, ecology, and recombination rates, Listeria monocytogenes is
divided into four different phylogenic evolutionary lineages (I, II, III, and IV) (Zhu et al., 2005).
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Lineage I includes serotypes 1/2b, 3b, 3c, and 4b and is responsible for outbreaks of human
clinical listeriosis (Ward et al., 2010b). Lineage II consists of serotypes 1/2a, 1/2c, and 3a and
exhibits a significantly higher prevalence among food isolates, the environment, and animal
clinical cases (Gray et al., 2004; Nightingale et al., 2005). Lineage III (serotypes 4a and 4c)
formerly consisted of two groups, lineages IIIA/C and IIIB/C, which are now considered lineage
III and lineage IV, respectively (Liu et al., 2006). However, limited knowledge exists for lineage
IV due to the rarity of strains in this lineage and low strain variability, which contributes to seven
unclear serotypes. Lineage III and IV strains account for approximately 1% of human listeriosis
cases but are more prominent in animals (Jeffers et al., 2001). Most human listeriosis outbreaks
have been linked to serotype 4b (lineage I) strains, while most sporadic human listeriosis cases
appear to be caused by serotype 4b (lineage III) or serotype 1/2a (lineage II) strains (Liu, 2006).
Listeriosis and pathogenesis
L. monocytogenes can be found in the gastrointestinal tract of individuals who remain as
asymptomatic carriers. Listeriosis may occur in one of two forms: non-invasive and invasive.
Non-invasive listeriosis is the mild form of disease and occurs in healthy adults. It is generally
limited to gastrointestinal illness, fever, vomiting, and diarrhea. The degree of severity is
dependent on characteristics of the host and the strain. Invasive listeriosis is the more severe
form of the disease. Most commonly, invasive listeriosis affects high-risk groups, including
children, the elderly, pregnant women, and the immunocompromised. With the onset of
epidemics such as HIV/AIDS, there has been an increase in the size of the population at risk of
morbidity and mortality due to listeriosis (Schlech et al., 1983). Invasive listeriosis is
characterized by systemic infection leading to septicemia, meningitis, meningoencephalitis, or
febrile gastroenteritis, and it can cause stillbirths and abortions (Vazquez-Boland et al., 2001).
4

The infective dose is dependent on immunity of the infected individual and the strain.
The definite infective dose has not yet been definitively determined, but it may be less than 1000
bacteria in the immunocompromised individual. The incubation period can range from a few
days to three weeks and may be preceded by gastrointestinal symptoms that manifest after
approximately 12 h incubation (Mead et al., 1999). The rate of normal healthy adult infection
from listeriosis is low. There are approximately 0.7 cases per 100,000 persons. However, the
infection is more common in children (10 cases per 100,000 persons) and the elderly (1.4 cases
per 100,000 persons) (Gellin et al., 1991). Pregnant women are seventeen times more likely than
healthy adults to acquire the infection (Jinneman and Hill, 2001).
The Centers for Disease Control and Prevention (CDC) estimates that around 48 million
Americans get sick, and around 3000 people die of foodborne illnesses annually
(https://www.cdc.gov/foodborneburden/). Listeriosis is estimated by the CDC to be the third
leading cause of death from foodborne illness with an approximate 20% case fatality rate; nearly
all cases are hospitalized (https://www.cdc.gov/listeria/technical.html).
L. monocytogenes causes about 260 deaths every year in the U.S. (Mead et al., 1999).
Although the actual number of infections is low, the mortality rate can be as high as 20-30%
regardless of antimicrobial treatment; thus, it has the highest hospitalization rate of the foodborne
pathogens.
There have been several sporadic and epidemic outbreaks worldwide that implicate
Listeria monocytogenes contaminated foods (Murray et al., 1926; Schlech et al., 1983). Foods
that are commonly implicated include ready to eat (RTE) foods (deli meats, salads etc.),
unpasteurized dairy foods (cheese and milk), cured and raw meats (hot dogs, undercooked
chicken), and items such as prepared seafood salads and even raw and unprocessed meats
5

(Schlech et al., 1983). Treatment of listeriosis depends on the severity of clinical signs. Mild
forms of listeriosis require no treatment. Invasive listeriosis can be treated with antimicrobials,
but more-serious listeriosis can be untreatable or resistant (Lamont et al., 2011).
Several factors contribute to L. monocytogenes pathogenicity and virulence. Listeria
monocytogenes express Internalin A and Internalin B which helps in internalization and invasion
of the host intestinal and endothelial cells ( Pentecost et al., 2010). Inside the host cells L.
monocytogenes express phospholipases and listeriolysin O. Both help the bacteria to escape from
the phagocytic cells and allowing Listeria to replicate inside the cytosol of the host cell. New
studies on the factor effect on L. m pathogenicity reveled that some surface protein plays critical
role in L. monocytogenes virulence. ActA is one of L. m surface proteins that is best
characterized as a virulence factor of L. m. It fulfils many essential functions within host cells,
allowing L. m to escape from autophagy and recruiting an actin polymerization complex that
promotes L. m motility, cell-to-cell spread and dissemination within host tissues. ActA also acts
extracellularly by mediating L. m aggregation and biofilm formation in vitro and in vivo (
Travier et al., 2014).
Identification of Listeria monocytogenes species
Listeria species possess distinct biochemical properties that can be used for speciesspecific identification. Therefore, some biochemical tests are useful for discriminating between
Listeria species. However, biochemical methods for the identification of Listeria species are
laborious, involving primary isolation with selective and enrichment media, followed by multiple
biochemical tests (Rocourt, 1999). Also, biochemical testing of Listeria species is timeconsuming (up to 6 days to finalize a result) and expensive (Liu, 2006). Also, biochemical tests
can be influenced by external factors that affect bacterial growth and metabolic mechanisms.
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Although serotyping is not very discriminatory, it is a universally accepted subtyping
technique for L. monocytogenes. The species is currently classified into 14 serotypes based on
variation in the somatic (O) and flagellar (H) antigens (Seeliger and Höhne, 1979). Identification
of the strain serotype permits differentiation between important food-borne strains and provides a
“gold standard” for comparing isolates (Borucki and Call, 2003; Nho et al., 2015b). L.
monocytogenes serotypes 1/2a (lineage II), 1/2b, and 4b (lineage I) are responsible for 98% of
documented human listeriosis cases, whereas serotypes 4a and 4c are rarely associated with
outbreaks of the disease (Wiedmann et al., 1996). Furthermore, while L. monocytogenes serotype
4b strains are isolated mostly from epidemic outbreaks of listeriosis, serotypes 1/2a and 1/2b are
linked to sporadic L. monocytogenes infection (Wiedmann et al., 1996). Because serotyping
requires acquiring subtype-specific antisera, serotyping methods are not routinely performed in
clinical laboratories. Additionally, serotyping does not correlate with species identities, which
limits its widespread clinical use (Liu, 2006).
PCR-based subtyping procedures have provided additional tools for the identification and
grouping of L. monocytogenes (Doumith et al., 2004; Jinneman and Hill, 2001). PCR-based
methods are more rapid, simpler to perform, less costly, and many laboratories with molecular
capability already have the necessary equipment, trained personnel, and reagents available.
However, because the assay sometimes depends on the selective amplification of a shared gene,
size fractionation of the amplicons may be required using standard agarose gel electrophoresis
(Versalovic et al., 1991). A multiplex PCR assay (Bubert et al. 1999) facilitates the
differentiation of six Listeria species based on selective amplification of iap gene (Bubert et al.,
1999). This assay depends on differentiating small differences in iap gene size among various
Listeria species. Species-specific primers for the six Listeria species were developed that
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achieved satisfactory specificity in the identification of each of the Listeria species (Liu et al.,
2003, 2004). Targeting Listeria genes unique to individual species is beneficial because
differentiation is based on the presence or absence of an amplicon rather than determining
amplicon size (Gilot and Content, 2002). However, co-presence of several Listeria species
complicates the identification of L. monocytogenes.
DNA sequencing methods of one or more particular genes are established and used for
genetic subtyping of L. monocytogenes (Cai et al., 2002). The accessibility of DNA sequencing
data also aids the reconstruction of ancestral and evolutionary relationships among L.
monocytogenes isolates (Ward et al., 2004, Ward et al., 2010b). For example, a multilocus
genotyping (MLGT) method was developed that uses 30 probes to classify L. monocytogenes
isolates into genetic lineage (I to IV), major serogroup (4b, 1/2b, 1/2a, and 1/2c), and epidemic
clone (EC) type (ECI, ECIa, ECII, and ECIII). A panel of 501 L. monocytogenes isolates from
ready to eat (RTE) meat and poultry products was evaluated using this MLGT and sequencing of
the virulence gene inlA (encoding internalin A), revealing that the percent of clonal lineages
associated with epidemic outbreaks that are contaminants of RTE foods and was less than 7.6%
(Ward et al., 2010a). With the cost of DNA sequencing decreasing rapidly, DNA sequencingbased subtyping can play an important role in L. monocytogenes subtyping and phylogenetic
studies, but it requires DNA sequencing equipment and trained personnel.
Thus, there is an urgent need for the development of a detection method that could be
very simple and potentially be used in the field or production plant. Biomarkers have the
potential for use in clinical practice for disease diagnoses, monitoring, and patient care. They
provide a detached and quantifiable method to diagnose and characterize disease agents.
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Identification of bacteria species based on variations in protein sequences (mass
spectrometry)
In recent years, proteomics-based approach and mass spectrometry (MS) through mass
fingerprinting or peptide sequencing analysis has become an established tool for microbial
identification and diagnostics and typing of bacteria (Singhal et al., 2015). As mass spectrometric
techniques and proteomic tools become increasingly available and accessible, a broader range of
researchers is applying these approaches to fit the specific needs of their projects (Baldwin,
2004).
Both matrix-assisted laser desorption ionization-time of flight mass spectrometry
(MALDI-TOF MS) and liquid chromatography-mass spectrometry (LC/MS) have a wide range
of applications including rapid bacterial identification in food‐borne disease outbreaks, water
quality control, antibiotic susceptibility/resistance tests, rapid infectious disease diagnosis, and
biomarker discovery that may help accurately identify closely related organisms (Cheng et al.,
2016). Moreover, MS has the potential for rapidly distinguishing between pathogenic and
nonpathogenic species of bacteria (Barbuddhe et al., 2008; Holland et al., 1996; Karcher et al.,
2018; Saenz et al., 1999). Mass spectra obtained from unknown bacterial samples can be used for
comparison with reference libraries of known species to facilitate identification (Holland et al.,
1996; Barbuddhe et al., 2008).
In general, mass spectrometers employed in proteomic analysis are based on the analysis
of peptides generated by proteolytic digestion of whole proteome or proteins of interest
(Aebersold and Mann, 2003). The most widely used enzyme is trypsin, which hydrolyzes the
protein on the C-terminal side of lysine and arginine (unless the subsequent amino acid in the
sequence is a proline) (Peng and Gygi, 2001). After digestion, the peptide mixture is commonly
separated by HPLC or by reverse-phase (RP) LC and introduced online into a mass spectrometer
9

via electrospray ionization (ESI) (Dreger, 2003). Following mass analysis of the fragment ions
resulting from peptide dissociation, the experimental data are usually searched in silico against
theoretical peptides created from predicted protein sequences using database-searching
algorithms (Eng et al., 1994). Peptide identifications are then correlated to protein sequences in
the database to identify the source proteins.
LC/MS technique provides high molecular specificity and detection sensitivity. LC/MS
can be used to analyze complex samples of environmental and biological origin. Therefore, LCMS may be applied in biotechnology, environment monitoring, food processing,
and pharmaceutical industries (Gaspari et al., 2016). Another advantage of using LC/MS is that
minor differences among isolates at subspecies level, or different growth conditions for the same
isolate, can be observed (Cheng et al., 2013; Kooken et al., 2014; Paul et al., 2007).
Application of MS and proteomics for identifying pathogenic bacteria
Mass spectral-based technologies have potential for the discovery of biomarker peptides
or proteins, which must then be validated (Hale et al., 2003). MS has been applied on multiple
bacterial species using comprehensive proteomic analysis to identify unique surface molecules,
marker proteins, or toxins that allow differentiation between isolates (Fenselau and Demirev,
2001; Krishnamurthy et al., 1999; Wang et al., 2002; Williams et al., 2004). Protein biomarkers
from intact bacteria are useful for the identification of bacterial species or intra-species
differentiation between different strains of bacteria (Arnold and Reilly, 1998; Demirev et al.,
1999; Ho and Hsu, 2002). MALDI-TOF was used to accurately identify 146 strains of
different Listeria species and correctly classified all L. monocytogenes serotypes in agreement
with PFGE (Barbuddhe et al., 2008).
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In a previous study using mass spectrometry with MALDI-TOF, six protein biomarkers
from two strains of Escherichia coli O157:H7 and one non-O157:H7 (nonpathogenic) strain of
E. coli were identified. The six biomarkers were novel for differentiating pathogenic E. coli
O157:H7 from nonpathogenic strains of E. coli using MALDI-TOF, whereas MALDI-TOF
failed in differentiating pathogenic E. coli O157:H7 from non-O157:H7 in this study. The
proteins identified were acid stress chaperone-like proteins; cold shock protein; YbgS (or
homeobox) protein; putative stress-response protein YjbJ (or CsbD family protein); and a protein
of unknown function (Fagerquist et al., 2010).
In Campylobacter jejuni, MS analysis was used to differentiate between 104 previously
characterized C. jejuni isolates from humans, chicken, turkey, and bovine. All samples were
identified as C. jejuni, and the method discerned mass peaks to identify subtypes (Zautner et al.,
2013). In another study, several protein biomarkers of three C. jejuni strains (RM1221, RM1859,
and RM3782) were identified by MS and proteomic techniques. The protein biomarkers
identified were: DNA-binding protein HU, translation initiation factor IF-1, cytochrome c553, a
transthyretin-like periplasmic protein, chaperonin GroES, thioredoxin Trx, and ribosomal
proteins (Fagerquist et al., 2006).
Streptococcus agalactiae (170 isolates) was examined by mass spectrometry, and their
tryptic peptides were analyzed by LC-MS/MS to identify four biomarkers that were significantly
associated with invasive ST17 genogroups (Lanotte et al., 2013). The four biomarkers are: small
subunit of exodeoxyribonuclease VII, 50S ribosomal protein L7/L12, CsbD-like protein, and
thioredoxin.
To identify a useful protein biomarker to distinguish between a pathogenic V.
parahaemolyticus O3:K6 strain (VP47) and another distantly related V.
11

parahaemolyticus O4:K55 strain, analysis of the lysates from whole bacteria by LC/MS revealed
differences in the masses of several proteins in each strain (Williams et al., 2004).
A number of studies demonstrated that analysis of changes in protein or peptide content
in biological fluids such as serum, urine, or milk is useful to discover biomarkers for diagnosis
and monitoring of diseases such as renal disorders, cardiovascular disease, mastitis, and diabetes
(Good et al., 2010; Metzger et al., 2010). For example, comparison of the peptidome between
healthy udders and udders infected with Staphylococcus aureus (mastitis milk) identified 154
peptides that have potential for diagnosis of mastitis (Mansor et al., 2013).
Therefore, identification of biomarkers unique to L. monocytogenes genetic lineage III
will help to distinguish high-risk Listeria monocytogenes serotypes from low-risk serotypes.
Additionally, it will be useful for studying the epidemiology of foodborne disease and
development of preventive strategies that could be very simple and potentially be used in the
field or production plant.
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CHAPTER II
DISCOVERY AND UTILIZATION OF PROTEIN BIOMARKERS DIFFERENTIATING
LISTERIA MONOCYTOGENES GENETIC LINEAGE III
Abstract
Listeria monocytogenes is the causative agent of listeriosis, a severe foodborne illness
characterized by septicemia, meningitis, encephalitis, abortions, and occasional death in infants
and immunocompromised individuals. L. monocytogenes is composed of four genetic lineages (I,
II, III, and IV) and at least twelve serotypes. The aim of the current study was to identify proteins
that can serve as biomarkers for detection of genetic lineage III strains based on simple antibodybased methods. Liquid chromatography (LC) with electrospray ionization tandem mass
spectrometry (ESI MS/MS) followed by bioinformatics and computational analysis were
performed on three L. monocytogenes strains (Lm33007, Lm33014, and Lm33077), which were
used as reference strains for lineage I, II, and III, respectively. Results from ESI MS/MS
revealed 42 unique proteins present in Lm33077 and absent in Lm33007 and Lm33014 strains.
BLAST analysis of the 42 proteins against a broader panel of >80 sequenced strains from
lineages I and II revealed four proteins [membrane protein (ST33077_2770), DUF3916 domaincontaining protein (ST33077_1897), DNA methyltransferase (ST33077_1926), and Type IV
secretion protein Rhs (ST33077_1129)] that have no homology with any sequenced strains in
lineages I and II. The four genes that encode these proteins were cloned into expression vector
pET28a, expressed in E. coli strain DE3, and purified by His-Bind resin. Polyclonal antibodies
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were prepared against purified recombinant proteins. ELISA using the polyclonal antibodies
against 12 L. monocytogenes lineage I, II, and III isolates indicated that proteins ST33077_2770
and ST33077_1926 detected all lineage III strains with no reaction to lineage I and II strains. In
conclusion, proteins ST33077_2770 and ST33077_1926 are potentially useful biomarkers for
detection and differentiation of L. monocytogenes lineage III strains in clinical, environmental,
and food processing facilities. Furthermore, these results validate the approach of using a
combination of proteomics and bioinformatics to identify useful protein biomarker.
Introduction
Listeria monocytogenes is a Gram-positive intracellular pathogen of animals and humans
(Murray et al., 1926). It has been implicated within the past decade as the causative agent in
several outbreaks of foodborne disease, and it currently has the third highest mortality rate (24%)
among foodborne pathogens. In the United States L. monocytogenes is responsible for about 260
deaths each year. It is ubiquitous in the environment, including water and soil, and it can resist
high salt concentration, low and high temperature (-1 - 45 0C), and low pH (Harrigan, 2001).
This capacity for tolerating extreme conditions makes it of particular concern for the food
industry, especially because it can be carried asymptomatically by multiple animal species. As a
result, it has been isolated from raw and processed foods, including chicken, red meat, seafood,
and milk.
Listeria monocytogenes causes listeriosis, a serious foodborne infection with high
hospitalization and mortality rates (20 to 30% mortality in high-risk individuals) (Farber and
Peterkin, 1991; Schlech et al., 1983). The most common form of the disease occurs mainly in
healthy individuals. Illness typically occurs 24 h after ingestion of a large inoculum of bacteria
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and usually lasts two days with gastroenteritis-like symptoms. The less common but more severe
form of the disease is found mainly among pregnant women and immunocompromised persons,
with symptoms of abortion, neonatal death, septicemia, and meningitis (Vazquez-Boland et al.,
2001).
Based on classical molecular subtyping methods, such as ribotyping, pulse field gel
electrophoresis (PFGE) and multi locus sequence typing (MLST), L. monocytogenes strains are
grouped into four distinct phylogenetic lineages (I, II, III and IV). Lineage I includes strains of
serotypes 1/2b, 3b, 4b, 4d, and 4e; this lineage is more commonly associated with human clinical
cases. Most outbreaks of listeriosis are caused by this lineage. Lineage II includes strains of
serotypes 1/2a, 1/2c, 3a, and 3c (Nho et al., 2015a), which is mostly isolated from food and
environmental samples causing sporadic listeriosis. Lineage III includes strains of serotypes 4a
and 4c, as well as certain strains of serotype 4b commonly isolated from animals. Strains in this
lineage are typically lower risk for causing listeriosis (Nadon et al., 2001; Rasmussen et al.,
1995; Ward et al., 2010a).
L. monocytogenes can be differentiated through culture methods based on selective
enrichment and plating, followed by characterization based on colony morphology, sugar
fermentation, and hemolytic properties (Jacquet et al., 2002). These methods are the gold
standard, but they are lengthy and may not be suitable for testing of foods with short shelf lives.
As a result, more rapid tests were developed based on molecular techniques (PCR or DNA
hybridization). However, some PCR techniques are complicated and require two or three
independent PCR reactions (Mead et al., 2005; Pan et al., 2009). Other PCR techniques are
limited and differentiate only two or three serotypes (Borucki and Call, 2003; Tresse et al.,

25

2007). Thus, there is an urgent need for the development of a rapid method that can distinguish
high-risk L. monocytogenes serotypes from low-risk serotypes.
Because lineage III strains are low risk for human listeriosis, we sought to identify
protein biomarker(s) that could distinguish L. monocytogenes genetic lineage III isolates from
lineages I and II isolates using simple antibody-based method for distinguishing lineages. This
work will enable studies on the epidemiology of listeriosis and the development of preventive
strategies.
In the current study, we applied liquid chromatography mass spectrometry (LC/MS)
proteomics to identify unique proteins of L. monocytogenes lineage III strain ST33077. Mass
spectrometry identified a total of 42 distinct proteins in strain ST33077 with no ortholog in
representative strains from L. monocytogenes genetic lineages I and II. BLAST analysis of
lineage III-unique proteins (42) against a panel of 80 L. monocytogenes Reference Sequence
proteomes (representing lineages I, II, and III) revealed twenty proteins without protein
homology with proteins from linages I and II. Four proteins out of twenty were chosen for
further studies based on peptide coverage and identity. These proteins have potential to develop
antibody-based separation methods for differentiating L. monocytogenes genetic lineages III
from lineage I and II. Development of simple antibody-based methods for differentiating L.
monocytogenes genetic lineages, serotypes, and epidemic clones would facilitate identification of
listerial subgroups in diagnostic microbiology laboratories and ostensibly in food processing
facilities. This increased discriminatory capability would assist in assessment of risk from L.
monocytogenes isolates and accelerate epidemiological investigations.
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Materials and Methods
Bacterial cultures and ethics statement
Polyclonal antibody production in rabbits was performed at Mississippi State University
according to a protocol approved by the MSU Institutional Animal Care and Use Committee
(IACUC-18-137).
Bacterial strains used are listed in (Table A.1) L. monocytogenes genome sequence for
strains 33007, 33014 and 33077 were provided by Todd J. Ward. L. monocytogenes strain 33077
(genomovar III; serotype 4a) was obtained from USDA-ARS and used for development of a
DNA probe-based method for differentiation of L. monocytogenes serogroups (Ward et al.,
2010b).
Hence, it served as the reference genetic lineage III strain for the current study. L.
monocytogenes strains were grown on brain heart infusion (BHI) agar and broth (Difco, Sparks,
MD, USA) and incubated at 37°C. Escherichia coli strain Nova Blue (Novagen, Madison, WI,
USA) was used for gene cloning in pET-28a expression vector (Novagen). Three recombinant
proteins (WP_012582068.1, WP_003728958.1, and WP_014589151.1) were expressed in
BL21(DE3) (EMD Millipore, San Diego, CA), and one protein (WP_077954308.1) was
expressed in C41(DE3) (EMD Millipore). All E. coli strains were cultured on Luria–Bertani
(LB) agar or broth (Difco) at 37°C. Kanamycin (Kan: 30 µg/ml) (Sigma–Aldrich, Saint Louis,
MN, USA) was added to culture medium for plasmid selection when needed, and isopropyl-β-Dthiogalactopyranoside (IPTG, Sigma was added for protein induction when needed.

27

Protein extraction and fractionation
Total proteins were isolated in triplicate from L. monocytogenes strains Lm-33007, Lm33014, and Lm-33077 (lineage I, II and III, respectively) using a phenol-based extraction
protocol with some modifications (Hurkman and Tanaka, 1986). Washed L. monocytogenes
bacteria were resuspended in ice-cold extraction buffer (0.9 M sucrose, 0.5 M Tris-base, 0.05 M
Na2-EDTA, 0.1 M KCl, 2% β-mercaptoethanol, 8 mM PMSF, pH 8.7) and sonicated with five
10-s pulses (Fisher Scientiﬁc Model 100 Sonic Dismembrator, setting 3) on ice with a minimum
of 1 min cooling time between pulses. Lysates were further treated with DNase (85 µg/mL) and
RNase (20 µg/mL) at 37oC for 30 minutes. Proteins were extracted by adding an equal volume of
Tris-buffered phenol (pH 8) and homogenizing for 10 minutes at room temperature. Insoluble
matter, phenol, and aqueous phases were separated by centrifugation at 5,500 g at 4oC. The
phenol phase was collected and extracted with ice-cold extraction buffer two more times using
the same procedure. Proteins were then precipitated from the phenol phase with five volumes of
0.1 M ammonium acetate and 2% β-mercaptoethanol in 100% methanol overnight at -20oC.
Precipitated proteins were washed three times with the same solution and three times with 100%
acetone. Air-dried protein pellets were stored at -20oC.
For protein fractionation and digestion, L. monocytogenes protein pellets were dissolved in 1x
SDS sample buffer (2% SDS, 50 mM Tris-HCl pH 6.8, 10% glycerol; 1% DTT) and quantified
using a 2D Quant Kit (GE Healthcare, Chicago, IL). To increase coverage of each proteome, 350
µg of proteins were fractionated into twelve molecular weight (MW) fractions using Sage ELF
(Sage Science; Beverly, MA). After fractionation, protein purity was verified using Bioanalyzer
(Agilent Technologies, Santa Clara, CA). Fractions were desalted on HiPPR spin columns
(Thermo Fisher Scientific, Waltham, MA). In-solution digestion was conducted as follows: each
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fraction was reduced with 100 mM DTT (15 min at 65oC), alkylated with 100 mM
iodoacetamide (IAA) 30 min at room temperature in the dark, and digested overnight with
Trypsin/Lys-C Mix (Promega, Madison, WI) at 37oC. Tryptic peptides were acidified with
formic acid, concentrated by Speed-Vac, and stored at -80oC. Immediately be mass spectrometry,
they were dissolved in 2% acetonitrile/0.1% formic acid and subjected to LC-MS/MS.
Protein fractionation was performed at Institute for Genomics, Biocomputing and Biotechnology
(IGBB).
Mass spectrometry and bioinformatics analysis
Trypsin-digested protein fractions from three L. monocytogenes strains were subjected to
qualitative proteomics analysis using LC-MS. Peptides were separated using C18 column and
HPLC directly linked to an LTQ Orbitrap mass spectrometer. Mass spectra were collected in
data-dependent analysis (DDA) mode during a three hours-long acetonitrile gradient. Complete
open reading frames (ORFs) and translated proteins were predicted using EMBOSS (v 6.6.0).
The raw data files were converted to “MGF” format and matched against the ORF database
using X!Tandem (v2017.2.1.4). For each strain, search results from the strain specific ORF
database were filtered to reduce the false discovery rate to less than 5% using the MSnID R
package. Results were filtered further by removing all spectra that matched theoretical ORF
databases from ST33007 and ST33014 (genomovars I and II) to yield candidate genomovar IIIspecific spectra.
Bioinformatics analysis identified 232,470 spectra that were identified in Lm33077
(lineage III) and not in lineage I and II. The unique spectra mapped to 1,522 ORFs with an ORF
FDR ≤ 0.05. Of those ORFs, a total of 42 distinct proteins were detected in strain ST33077 that
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did not match L. monocytogenes strains ST33007 and ST33014 with less than 50% identity.
BLAST analysis of the putative Lineage III-specific proteins was conducted against 80 L.
monocytogenes strains from lineages I and II in the NCBI Reference Sequence proteome
database, and 20 proteins were identified that did not match any strains from lineages I and II.
The four of these 20 proteins that were most unique to lineage III (based on peptide coverage and
identity of all three lineages) are WP_012582068.1, WP_003728958.1, WP_014589151.1, and
WP_077954308.1 (ST33077_1897, ST33077_2770, ST33077_1129, and ST33077_1926). These
proteins were selected for further analysis to determine their function and suitability as
biomarkers for antibody-based detection of L. monocytogenes genetic lineage III.
Mass Spectrometry and Bioinformatics analysis were performed at IGBB.

Construction of recombinant plasmids, protein expression and purification.
PCR amplicons for the four genes (ST33077_1897, ST33077_2770, ST33077_1129, and
ST33077_1926) were amplified from L. monocytogenes ST33077 genomic DNA using the
primer pairs shown in (Table A.2). Restriction endonuclease sites were incorporated at the 5' end
of each primer. The four amplified products were purified with the QIAquick PCR purification
kit (Qiagen, Valencia, CA, USA). Cleaned PCR products were digested with two restriction
endonucleases, and the size of the digested fragment was analyzed on 1% agarose gel using
electrophoresis. Each processed DNA fragment was ligated to pET28a digested using
appropriate restriction enzymes. Ligation mixtures were transformed to chemically competent
Nova Blue E. coli K12 using manufacturer’s protocol (Table A.3). Positive clones were selected
on LB agar plates with kanamycin. Candidate plasmids with appropriate fragment patterns were
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sequenced using T7 promotor and T7 terminator primers to confirm correct orientation of the
insert. Three resulting recombinant plasmids pET28a_1897, pET28a_2770, and pET28a_1129
were transformed into E. coli BL21(DE3), while (pET28a_1926) was transformed into E. coli
C41(DE3) because of low level of expression in BL21 (DE3) (Table A.3).
Expression of ST33077_1897, ST33077_2770, and ST33077_1129 proteins in E. coli
BL21 (DE3) and ST33077_1926 protein in E. coli C41 (DE3) were optimized in 250 ml cultures.
Expression in the bacteria was induced at an optical density 0.6- 0.8 nm (OD600) by adding IPTG
ranging from 1 mM to 100 mM final concentration. Induced cultures were incubated overnight in
temperatures ranging from 18-37 oc. Cell cultures at different time points (2, 4, 6, 8, and 18 h)
were prepared and analyzed by electrophoresis in 12% SDS-PAGE. Non-recombinant bacteria
and un-induced recombinant clones were used as controls (Abdelhamed et al., 2016).
Purification of the four recombinant proteins ST33077_1897, ST33077_2770,
ST33077_1129, and ST33077_1926 containing six histidine tags was done using His-Bind
(Novagen) resin column according to the manufacturer’s protocols (Abdelhamed et al., 2016).
The recombinant clones ST33077_1897 and ST33077_2770 were grown in 250 ml of LB broth
and induced by 1 mM final concentration IPTG for 18 h at 18 oc. Recombinant clones
ST33077_1129 and ST33077_1926 were grown in 250 ml of LB broth and induced by 100 mM
IPTG. Bacteria were then harvested by centrifugation (6000 g for 20 min at 4 ºC), and the pellet
was lysed using 8 M urea, 50 mM Tris–HCl (pH 8.0), 10 mM EDTA, and 10 mg/ml lysozyme,
followed by sonication (6 cycles, 30 s) on ice. The sonicated suspension of three proteins
(ST33077_1897, ST33077_2770, and ST33077_1129) were subjected to centrifugation and
collected for protein purification step. For ST33077_1926 the pellet was washed with 0.2 M
sodium phosphate buffer (pH 7.3), 1 mM EDTA, 50 mM NaCl, 5% glycerol, and 1 M urea,
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followed by washing with homogenization buffer (50 mM Tris–HCl (pH 8.0), 100 mM NaCl, 0.5
% TritonX-100, 0.1 % sodium-azide). The pellet was solubilized in 6 M guanidinium chloride,
10 mM Tris–HCl (pH 8.0), 500 mM NaCl for 1 h at 4°C followed by centrifugation. The
clarified supernatant was loaded onto a His-Bind column prepacked with Ni2+-charged resin that
had been pre-equilibrated with 10 ml of binding buffer. Non-specific proteins were removed by
applying binding buffer followed by wash buffer (6 M urea, 500 mM NaCl, 20 mM imidazole,
and 20 mM Tris-HCl [pH 7.9]). Recombinant proteins were then eluted with 6 M urea, 1 M
imidazole, 250 mM NaCl, and 10 mM Tris-HCl. Purity of the proteins was determined by 12%
SDS-PAGE analysis. Protein yield was determined on a spectrophotometer at 280 nm.
Polyclonal antibody production and antibody titer analysis
A total of eight 10-week-old specific pathogen free (SPF) New Zealand white rabbits
were housed separately in stainless steel cages and allowed free access to complete pelleted
rabbit diet and water. Rabbits were acclimated for seven days before use. Two rabbits were used
to produce polyclonal antibody against each recombinant protein.
On day 1, 3 ml of blood was collected from the ear vein of each rabbit to determine preimmunization antibody levels (control). The primary immunization with the purified proteins
(ST33077_1926, ST33077_2770, ST33077_1897, and ST33077_1129) was conducted in 1 ml
emulsion of sterile antigen and complete Freund’s Adjuvant. The ratio of antigen to adjuvant was
4:1 with a final concentration of 250 µg/ml of recombinant protein. Rabbits were administered
0.3 ml of the antigen/adjuvant mixture subcutaneously in four locations on the back and flank
regions.
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Two booster immunizations were performed at 14- 21-day intervals using emulsion with
incomplete Freund’s Adjuvant administered subcutaneously in four different locations. The ratio
of antigen to adjuvant was 2:1. Post-immunization blood samples were collected 7 and 21 days
after the 2nd booster injection to determine antibody titers using an enzyme-linked
immunosorbent assay (ELISA).
After a sufficient antibody response was developed, a final blood sample was collected
by intracardiac (IC) method under anesthesia with ketamine (15 mg/kg), dexmedetomidine
(0.125 mg/kg), butorphanol (0.2 mg/kg), and glycopyrrolate (0.01 mg/kg). Rabbits were
euthanized without recovery from anesthesia using dexmedetomidine reversed with atipamezole
(as needed).
Analysis of antibody titer in rabbit serum was done using two different methods of the
enzyme-linked immunosorbent assay (ELISA). In the first method, a 96-well ELISA plate
(Bloomington, MN, U.S.A) was coated with the purified recombinant proteins. The purified
protein sample was diluted to 20 mg/ml final concentration using sterile PBS, 100 μl per well. In
the second method, a 96-well ELISA plate (Bloomington, MN, U.S.A) was coated with
inactivated bacterial suspension. L. monocytogenes strains (listed in Table 1) were cultivated to a
concentration of 108 CFU/ml, heat inactivated for 3 h, washed, and suspended in sterile Hank’s
balanced salt solution (HBSS).
For both ELISA methods, 100 µl rabbit serum diluted 1:100 was added to each well.
After washing, goat anti-rabbit IgG antibody conjugate (Fisher Scientific) was used for detection
with p-nitrophenyl phosphate substrate (Sigma 104 phosphatase substrate) dissolved in 10%
diethanolamine buffer. Absorbance was measured at 405 nm in an ELISA Microplate Reader
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(CA, USA). To standardize, average background absorbance for each plate was subtracted from
the measured absorbance for each well.
Automated Western Blot (WES) immunoassays were conducted using a fully automated
Simple WesternTM capillary instrument (Protein Simple, San Jose, CA) according to the
manufacturer’s protocol. For ST33077_1926, the assay was set up as follows: final concentration
of 5 µg/ml per well of protein diluted in PBS. Antibodies against ST33077_1926 were applied in
dilutions of 1:250, 1:500, 1:750, and 1:1000 as one dilution per well. For ST33077_2770, a final
concentration of 2. 5 µg/ml of protein diluted in PBS was used per well. Antibodies against
ST33077_2770 protein were applied in dilutions of 1:500, 1:1000, 1:2500, 1:5000, 1:7500,
1:10000, and 1:15000 as one dilution per well. Protein samples, antibodies, and reagents were
loaded on pre-filled cartridges. Serum (primary antibody) and anti-rabbit HRP-conjugated
secondary antibody were used for immunoprobing with chemiluminescent substrate, which took
place in the capillaries. Resulting assay data were automatically processed and analyzed by
Compass software (Protein Simple).
Automated capillary western blot technique was performed at IGBB.
Statistical analysis
The rabbit serum antibody response against the injected recombinant proteins (measured
by ELISA using plates coated with respective recombinant protein) was compared between the
preinjected serum and the 21 day post-immunization sera with mixed model logistic regression
using PROC GLIMMIX in SAS for Windows 9.4 (SAS Institute, Inc., Cary, NC, USA).
The variance in the mean difference in reactivity between preinjected serum and immune
serum for each protein against the mean of all four lineage I strains, four lineage II strains, and
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four lineage III strains was compared using PROC GLM Dunnett in SAS for Windows 9.4.
Additionally, a multiple variant comparison of the mean difference in reactivity for each genetic
lineage III strain was done separately against the mean differences of all four lineage I and all
four II strains using PROC GLM with an adjustable P value.
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Results
Mass Spectrometry
LC/MS analysis revealed that 232,470 spectra were detected in Lm-33077 (lineage III)
and absent in Lm-33007 and Lm-33014 (lineage I and II respectively) with a false discovery
rate (FDR) ≤ 0.05. These spectra mapped to 1,522 ORFs, out of which 651 had unique peptides
present in Lm-33077 and not in Lm-33014 and Lm-33007. Out of the 651 ORFs with unique
peptides, 42 ORFs had no orthologs in Lm-33014 and Lm-33007.
These 42-candidate lineage III-specific proteins were identified based on a comparison of
three strains (one from each genetic lineage). To determine which of these 42 have the best
potential as biomarkers that would be uniquely present in all lineage III strains (and missing in
all lineage I and II strains), these 42 proteins were analyzed by BLAST against the proteomes of
80 sequenced L. monocytogenes strains (representing all three genetic lineages) available in
NCBI. Results revealed that 20 proteins out of 42 have less than 50% similarity (identity *
coverage) to any Lineage I and II proteins (Table A.4). The predicted function of the 20
candidate ORFs was determined and is shown in (Table A.5). Table A.6 shows the number of
peptides and the percent coverage of each ORF based on all unique peptides.
Four proteins (ST33077_1897, ST33077_2770, ST33077_1926, and ST33077_1129) out
of twenty had the highest peptide coverage in lineage III strains and lowest identity and coverage
in lineage I and II strains, and these four were selected for further analysis (See Discussion for
biological justification).
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Expression and purification of the recombinant proteins.
Four genes from L. monocytogenes ST 33077 (ST33077-1129, ST33077-1926, ST330772770, and ST33077-1897) were successfully cloned into pET28a vector. Successful cloning was
confirmed by restriction enzyme analysis and DNA sequencing. The result of expression analysis
revealed that the induced recombinant bacteria started expression of ST33077-2770 and
ST33077-1897 proteins after 6 h of induction with 1 mM final concentration of IPTG and
reached maximum expression after 18 h at 18 oC. On the other hand, induced E. coli started
expression of ST33077-1129 and ST33077-1926 proteins after 2 h of induction with 100 mM
IPTG and reached a maximum level at 6 h at 37 oC.
Recombinant ST33077-1129, ST33077-1926, ST33077-2770, and ST33077-1897
proteins were estimated to have a molecular weight of 107.73, 33.62, 20.91, and 21.15 kDa,
respectively. Each purified recombinant protein yielded a single band on sodium dodecyl sulfate
polyacrylamide gel electrophoresis (SDS-PAGE) which is higher than the expected molecular
weights by around 3 KDs for each protein (Figure A.1). This could be because of post translation
modification of the protein or because of expression of some vector peptides during the bacterial
culture induction with the IPTG. The identities of the four proteins were confirmed using LC-MS
analysis. The raw mass spectra data were matched to proteins using SEQUEST algorithm of
Proteome Discoverer program and translated ORF database of Lm33077. Sequences of matched
proteins were further searched by BLAST against L. monocytogenes database at NCBI.
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Rabbit serum antibody response
ELISA was used to determine the titers of the polyclonal antibody obtained from each
rabbit serum at 21 days after the second booster injection with ST33077-1897, ST33077-2770,
ST33077-1129, and ST33077-1926. When ELISA plates were coated with purified proteins,
immunized rabbit serum showed a significantly (p <.0001) higher antibody titer than the preimmunized rabbit serum for all four proteins (Figure A.2).
To determine the specificity of polyclonal antibodies for each recombinant protein,
reactivity of immune serum for each protein was determined against whole cell lysate from
twelve L. monocytogenes strains (four lineage III strains, four lineage I strains, and four lineage
II strains). Pre-injected rabbit sera and sera collected 21 days post-injection with the four purified
protein were tested against whole cell lysate of each representative strains in lineages III, I, and
II using ELISA to determine the reactivity of ST33077_1926, ST33077_2770, ST33077_1897
and ST33077_1129-specific rabbit immune serum against lineage I, II and III strains (Figures
A.3, A.4, A.5 and A.6).
To statistically compare the reactivity of immune serum for each recombinant protein to
lineage III, lineage I, and lineage II strains, the difference in reactivity between pre-injection
serum and immune sera for each L. monocytogenes strain was calculated, and the mean
difference in reactivity was determined for each protein against lineage III, lineage I, and lineage
II. When the mean difference in antibody reactivity for all four lineage III strains was compared
to the mean for all four lineage I and all four lineage II strains, significantly higher reactivity was
detected in serum against ST33077_1926 and ST33077_2770 in the plates coated with whole
cell lysate of L. monocytogenes genetic lineage III strains compared with the plates coated with
whole cell lysate of L. monocytogenes genetic lineages II and I (p <0.0001 and <0.0018,
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respectively) (Figures A.7 and A.8). By contrast, the mean difference in reactivity of serum
against Lm33077-1897 and Lm33077-1129 showed no significant difference between the plates
coated with whole cell lysate of L. monocytogenes genetic lineage III strains against plates
coated with whole cell lysate of L. monocytogenes lineages II and I strains (P = 0.6 and 0.68,
respectively) (Figures A.9 and A.10).
When the mean difference in antibody reactivity for each individual lineage III strain was
compared to the mean reactivity for all four lineage I and all four lineage II strains using multiple
variant comparison, all four lineage III strains (ST33077, RM3030, RM3170, and RM3171) had
significantly higher differences in antibody reactivity against ST33077_1926 protein compared
to the mean difference of all four lineage I strains and all four lineage II strains. However,
ST33077_2770 protein only had significantly higher differences in antibody reactivity in
RM3030 and RM3170 compared to the mean of all four lineage I strains and all four lineage II
strains. As expected, ST33077_1897 and ST33077_1129 did not show any significant difference
in antibody reactivity of any lineage III strain compared by the mean of antibody reactivity for
all four lineage I and II strains.
Automated Western Blots
Capillary Western blots were conducted to analyze purity and confirm the size of
recombinant ST33077_1926 and ST33077_2770. Compass software generates gel-like images of
immunoassays (Figures A.11 and A.12). For ST33077_1926, a single clear band was present at
1:1000 and 1:750 serum dilutions, and the size matched the predicted molecular weight for
ST33077_1926 (33.6 kDa). For ST33077_2770, a single clear band was visible at 1:7500 and
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1:10000 dilutions of serum. The band was approximately 40 kDa, which is about twice the
predicted molecular weight of 20.9 kDa, suggesting the protein may exist as a dimer.
Discussion
Several subtyping techniques using many L. monocytogenes strains identified four major
genetic lineages (Aarts et al., 1999; Aguilar-Bultet et al., 2018; Bibb et al., 1990; Piffaretti et al.,
1989), and specific serotypes are associated with each lineage. Lineage I strains are the most
frequently associated with clinical outbreaks of listeriosis. Lineage II strains also commonly
cause clinical listeriosis and are routinely found in food and environmental samples. Lineage III
strains are not as common. They are often isolated from animals, and they typically pose little
risk of causing disease in people (Aarts et al., 1999; Levenson, 2010; Tost, 2009).
Besides serology, differentiation of L. monocytogenes lineages currently relies on DNAbased technology. To date, there are no reported biomarkers useful for differentiating L.
monocytogenes genetic lineages. Because lineage III strains are low risk for human listeriosis,
we sought to identify protein biomarker(s) that could distinguish L. monocytogenes genetic
lineage III isolates from lineages I and II isolates. A protein biomarker could be used for
development of a simple antibody-based method for distinguishing lineages.
Another objective of the current study was to determine if mass spectrometry-based
shotgun proteomics could be used to identify candidate biomarkers. Our reasoning was that
mass spectrometry would be an efficient screening method compared to a purely bioinformaticsbased search for unique proteins because we could be assured that any candidate biomarker
proteins are actually expressed in detectable quantities prior to conducting labor-intensive
cloning and expression of candidate recombinant proteins. To test this method, we used three
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strains of L. monocytogenes, one representing each of the three genetic lineages. Electrospray
ionization tandem mass spectrometry was used to identify peptides from each of the strains, and
comparative proteomics analysis between the three strains yielded candidate proteins unique to
lineage III.
Proteome coverage was improved by running liquid chromatography-tandem mass
spectrometry in triplicate for each strain. Coverage was further improved by running a liquid
chromatography gradient based on molecular weight and running mass spectrometry on resulting
fractions. Increasing the gradient length enhances the number of protein identifications in
complex mixtures by reducing complexity of fractions, which increases sensitivity of mass
spectrometry output (Hsieh et al., 2013; Wang et al., 2015). Analysis of brain proteome
demonstrated that coupling of prefractionation with long gradient LC-MS/MS yielded higher
peptide numbers and increased protein coverage with less than 1% protein false discovery (Wang
et al., 2015).
After identification of potential lineage III-specific proteins based on mass spectrometric
analysis of three strain, an additional bioinformatic analysis was conducted to help select the best
candidate proteins for cloning and expression. BLAST analysis of each candidate lineage IIIspecific protein against a proteome database of >80 Listeria monocytogenes strains (representing
all three lineages) was conducted to account for strain sequence variation within each genetic
lineage and select candidate proteins consistently present in lineage III strains but with low
percent identity and coverage against all lineage I and II strains. The predicted functions of the
four candidate proteins include a DNA methyltransferase (ST33077_1926), type IV secretion
protein Rhs (ST33077_1129), a membrane protein (ST33077_2770), and a hypothetical
DUF3916 domain-containing protein (ST33077_1897).
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Membrane proteins are good potential biomarkers due to their surface exposure. Several
researchers used membrane proteins as biomarker for differentiating infectious L.
monocytogenes strains from noninfectious strains and CNS- related strains from non-CNS
related strains (Aguilar-Bultet et al. 2018). DNA methyltransferase proteins are potentially useful
as universal biomarkers in cancer cell detection (Wallden et al., 2010) and disease-associated
changes (Tost 2009).
Type IV secretion system (T4SS) is a large protein complex that plays an important role
in L. monocytogenes virulence (Schlech et al. 1938). Some T4SS proteins are expressed by L.
monocytogenes to translocate virulence proteins into the host cell (Green and Mecsas, 2016;
Levenson, 2010). Other T4SSs facilitate gene transfer, enabling adaptation to environmental
changes and probably in the spread of antibiotic resistance genes (Koskiniemi et al., 2014).
Cloning, expression and purification of the four-candidate lineage III-specific proteins
(ST33077_1926, ST33077_2770, ST33077_1897, and ST33077_1129 domain) were very
effective using pET28a (5369 bp) in E. coli with the T7 promoter. Cloning of the T4SS gene was
difficult due to its size (approximately 10 kbp), which is almost twice the plasmid size.
Therefore, approximately 2900 bp of the T4SS gene was cloned in pET28a expression vector,
which represents the rearrangement hotspot (Rhs) repeat domain. The Rhs domain has Rhs toxin
activity (Koskiniemi et al., 2013), which is found in both bacteria and eukaryotes, but the
function of this protein is not well studied (Chen et al., 2015). In gram-negative and grampositive bacteria, Rhs toxin functions as an intercellular competition mediator by inhibiting the
growth of neighboring cells (Chen et al., 2015). Rhs also functions as an immunity protein to
protect the bacteria from autoinhibition (Chen et al., 2015; Koskiniemi et al., 2013).
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ST33077_1897, ST33077_2770, and ST33077_1129 proteins showed a high level of
expression in BL21(DE3) E. coli in the insoluble fraction. However, ST33077_1926 protein
showed no expression after IPTG induction. Additionally, bacterial growth stopped immediately
after IPTG induction. Therefore, we used C41(DE3) E. coli, which is more resistant to some
toxic proteins, to express ST33077-1926, where it was isolated from inclusion bodies.
A lineage III-specific protein biomarker has the potential for development of a simple,
field-deployable antibody-based detection method. To begin testing the feasibility of this
approach, we developed polyclonal antibodies for each of the recombinant proteins. Some
background reactivity was detected against L. monocytogenes in all the rabbit sera, but all four
proteins stimulated significant antibody titers compared to pre-inoculation serum. The antibody
titers in pre-inoculation rabbit’s serum may be due to environmental exposure to L.
monocytogenes, which is common in the environment as a commensal and opportunistic
pathogen in rabbit’s intestine. Another factor likely contributing to the background antibody
reaction is that the ELISA plates were coated with L. monocytogenes whole cell lysate, so that
some reactivity could occur from other bacterial antigens.
Next, to determine the specificity of the polyclonal antibodies for detection of lineage III
L. monocytogenes, each was tested for reactivity against whole bacteria from the three original
strains (ST33077, ST33014, and ST33007) and nine additional L. monocytogenes strains
representing the three lineages (Table 1). Importantly, when the mean reactivity of serum against
all four lineage III strains was compared to the mean reactivity of serum against all four lineage I
and II strains, polyclonal antibodies against two of the proteins, ST33077_1926 and
ST33077_2770, showed significantly higher reactivity to L. monocytogenes lineage III strains
than lineage I and II strains. ST33077_1897 and the Rhs domain of ST33077_1129 did not have
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a significant difference in reactivity between lineages III, II, and I. Based on ELISA results
using four representative strains from each genetic lineage, ST33077_1926 and ST33077_2770
are promising proteins biomarkers for development of an antibody-based method to differentiate
L. monocytogenes genetic lineage III from lineage I and II.
Of the two potential biomarkers, ST33077_1926 has higher potential than ST33077_2770
as a biomarker because ST33077_1926-specific serum reacted significantly higher against each
of the four individual lineage III strains compared to the mean reactivity against all four lineage I
and lineage II strains. By comparison, ST33077_2770-specific serum only reacted significantly
higher against two of the four individual lineage III strains compared to the mean reactivity
against all four lineage I and lineage II strains.
Western blots based on capillary electrophoresis confirmed that the polyclonal antibodies
detected the recombinant proteins ST33077_1926 and ST33077_2770. The size of
ST33077_1926 was also confirmed (33.62 kDa). Western blot results suggest that
ST33077_2770 (20.9 kDa) exists as a dimer, but little information is published about this
protein, so this could not be confirmed. Capillary Western blots provided good sensitivity and
protein separation compared to traditional Western blots, and it reduces time and reagent
requirements (Beekman et al., 2018).
In conclusion, our results confirmed that ST33077_1926 and ST33077_2770 are promising
candidates as proteins biomarkers for differentiating L. monocytogenes genetic lineage III from
lineage I and II, which will facilitate identification of L. monocytogenes subgroups in diagnostic
microbiology laboratories and ostensibly in food processing facilities. This increased
discriminatory capability would assist in assessment of risk from L. monocytogenes isolates and
accelerate epidemiological investigations. Biomarkers for differentiating lineage I and II strains
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are yet to be identified, but the approach described in the current study shows promise for
identifying protein biomarkers for L. monocytogenes genetic Lineages I and II.
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Table A.1

Listeria monocytogenes strains used in this study

Strain
No.
Lm33077
Lm33014
Lm33007
RM2707
RM2995
RM3109
RM3000
RM3020
RM3102
RM3030
RM3170
RM3171

Serotype Genetic Lineage Source

Reference

4a

USDA-ARS
USDA-ARS
USDA-ARS
(Gorski et al. 2003)
(Gorski et al. 2004)
(Gorski et al. 2003)
(Gorski et al. 2004)
(Gorski et al. 2004)
(Gorski et al. 2004)
(Gorski et al. 2004)
(Gorski et al. 2004)
(Gorski et al. 2004)

1/2b
1/2b
1/2b
1/2c
1/2c
1/2a
4c
4c
4a

III
II
I
I
I
I
II
II
II
III
III
III

Unknown
Unknown
Unknown
Cheese
Cow brain
Unknown
Soil
Unknown
Monkey
Bull
Unknown
Unknown
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Table A.2
ORF

Primers used for PCR amplification
Primers

Primer Sequence

Restriction Amplicon
Enzymes size (bp)

ST33077_1897 Forward AAAGTCGACTTTTCCTATAAACCAAA* SalI

534

AAAGGATCCGGTATGGGGAATAAGGA
Reverse

BamHI

ST33077_2770 Forward AAAGGATCCATTTTCATGTTTAATAA BamHI

567

AAAGTCGACTTGGGCATCATTCGCTT
Reverse
SalI
ST33077_1926 Forward AAAGTCGACCACCACCCCTGCCTGAT SalI

920

AAAGGATCCGGATCCTTTATTCGTGCA
Reverse ATTAA
BamHI
ST33077_1129 Forward AAAGTCGACGGCACCGTCTTCGTGGT SalI

2900

AAAGCTAGCAAGGACCTGAAGACACA
Reverse

NheI

*Bold letters at the 5' end of the primer sequence represent restriction endonuclease site added.
AA nucleotides were added to the end of each primer containing a restriction endonuclease site
to increase the efficiency of enzyme cut.
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Table A.3

E. coli strains and plasmids

Strain or Plasmid Description

Reference or
source
Novagen

E. coli Nova
Blue

endA1 hsdR17 (rK12– mK12+) supE44 thi-1 recA1
gyrA96 relA1 lac F′[proA+B+lacIqZΔM15:Tn10]
(TetR)

E. coli
BL21(DE3)

F− ompT hsdS gal; expression host
F – ompT hsdSB (rB- mB-) gal dcm.

EMD
Millipore

E. coli C41
(DE3)
pET-28a

Subgroup from Bl21 (DE3) help plasmid stability

Lucigen

Expression vector; KmR

Novagen

pET28a_1897

pET28a with cloned ST33077_1897 amplicon

This study

pET28a_2770

pET28a with cloned ST33077_2770 amplicon

This study

pET28a_1129

pET28a with cloned ST33077_1129 amplicon

This study

pET28a_1926

pET28a with cloned ST33077_1926 amplicon

This study
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Table A.4

L. monocytogenes ST33077 proteins with less than 50% identity and coverage in
Lineages I and II strains
ORF

Lineage I (Identity *
Coverage) *

Lineage II (Identity *
Coverage)

ST33077_0135

NS†

NS

ST33077_0258

WP_003740445.1 (47.77)

WP_012951247.1 (47.32)

ST33077_0314

WP_003725659.1 (10.08)

NS

ST33077_0492

NS

NS

ST33077_0493

WP_023550422.1 (19.28)

NS

ST33077_0937

NS

NS

ST33077_1129

WP_061385917.1 (2.68)

NS

ST33077_1328

WP_003725868.1 (28.53)

WP_014602121.1 (28.15)

ST33077_1569

WP_003728189.1 (16.05)

WP_014601042.1 (10.39)

ST33077_1816

NS

NS

ST33077_1897

NS

NS

ST33077_1926

NS

WP_049962080.1 (26.68)

ST33077_2218

NS

NS

ST33077_2271

WP_003724612.1 (8.91)

WP_003731898.1 (8.91)

ST33077_2323

NS

NS

ST33077_2398

NS

NS

ST33077_2419

NS

NS

ST33077_2617

WP_021496264.1 (8.47)

NS

ST33077_2739

NS

NS

ST33077_2770

WP_003728337.1 (9.27)

NS

*Protein ID of the most similar protein in Lineage I or II and Identity*Coverage
†NS, no significant protein matches found by BLAST.
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Table A.5

Predicted functions of candidate Lineage III-specific proteins

ORF

NCBI ID*

Similarity†
(%)

ST33077_0135

NS‡

0

Function

ST33077_0258 WP_012581893.1 97

hypothetical protein

ST33077_0314 WP_039381474.1 10.8

guanylate kinase

ST33077_0492 WP_070220410.1 100

hypothetical protein

ST33077_0493 WP_070220412.1 100

hypothetical protein

ST33077_0937

NS

0

ST33077_1129 WP_014589151.1 94.2029

type IV secretion protein
Rhs

ST33077_1328 WP_003739362.1 28.534

oxidoreductase

ST33077_1569 WP_070221254.1 100

hypothetical protein

ST33077_1816

NS

0

ST33077_1897 WP_012582068.1 95

hypothetical protein

ST33077_1926 WP_077954308.1 100

DNA methyltransferase

ST33077_2218

NS

0

ST33077_2271 WP_070779485.1 9.54548

peptide ABC transporter
substrate-binding protein

ST33077_2323 WP_070219794.1 100

hypothetical protein

ST33077_2398 WP_070219932.1 100

hypothetical protein

ST33077_2419 WP_070219871.1 100

hypothetical protein

ST33077_2617 WP_070284542.1 13.1763

hypothetical protein

ST33077_2739

NS

0

ST33077_2770 WP_003728958.1 90

membrane protein

*Best BLAST hits in NCBI database
†Similarity between ST33077 protein and its best BLAST hit.
‡NS, no proteins with significant similarity were identified in the NCBI database.

54

Table A.6

Number of peptides identified by LC/MS for candidate Lineage III-specific
proteins and percent coverage of proteins by identified peptides
Protein

Number of
peptides

% Coverage

ST33077_0135

1

19.697

ST33077_0258

1

8.21918

ST33077_0314

1

9.42029

ST33077_0492

7

6.7623

ST33077_0493

1

4.8913

ST33077_0937

3

15.6522

ST33077_1129

1

0.87069

ST33077_1328

12

8.73016

ST33077_1569

7

19.4915

ST33077_1816

1

9.56522

ST33077_1897

3

21.4689

ST33077_1926

31

24.6528

ST33077_2218

1

3.76712

ST33077_2271

1

6.96203

ST33077_2323

16

7.22892

ST33077_2398

1

7.69231

ST33077_2419

4

20.7547

ST33077_2617

1

12.5

ST33077_2739

1

19.1781

ST33077_2770

100

29.8913
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Figure A.1

Confirmation of recombinant protein purity using SDS-PAGE. ST33077_2770
(A), ST33077_1897 (B), ST33077_1926 (C), and ST33077_1129 (D). Molecular
weight (KD) of bands in the Page-Ruler Pre-stained Protein Ladder (Thermo
Scientific, MAN0011772) are shown to the left of each image.
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0.5
0
ST333077-1897

ST33077-2770

Preinjection

Figure A.2

ST33077-1129

ST33077-1926

21 days after 2nd booster injection

Serum antibody response against recombinant proteins ST33077_1987,
ST33077_2770, ST33077_1129, and ST33077_1926.

Optical densities at 405 nm are means of four replicates of tested serum against the purified
protein (p<0.0001). Serum was collected 21 days after the second booster injection. Asterisks
indicate significantly higher antibody titer compared to pre-injection serum.
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PRE-INJECTION OF 1926

Lineage III strains

Figure A.3

Lineage II strains

RM3109

RM2995

RM2707

ST33007

RM3102

RM3020

RM3000

ST33014

RM3171

RM3170

POST INJECTION OF 1926

RM3030

4
3.5
3
2.5
2
1.5
1
0.5
0
-0.5

ST33077

OD 405 nm

ST33077_1926

Lineage I Strains

Reactivity of ST33077_1926-specific rabbit immune serum against representative
strains in lineages III, I, and II.

Antibody response was determined by ELISA using plates coated with whole cell lysate of each
strain shown using rabbit sera collected 21 days post-injection with ST33077_1926 purified
protein. Optical densities at 405 nm are means of two rabbits with four technical replicates each.
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Lineage III strains

Figure A.4

Lineage II strains

RM3109

RM2995

RM2707

ST33007

RM3102

RM3020

RM3000

ST33014

RM3171

RM3170

RM3030

POST INJECTION OF 2770

ST33077

OD 405 nm

ST33077_2770

Lineage I Strains

Reactivity of ST33077_2770-specific rabbit immune serum against representative
strains in lineages III, I, and II.

Antibody response was determined by ELISA using plates coated with whole cell lysate of each
strain shown using rabbit sera collected 21 days post-injection with ST33077_2770 purified
protein. Optical densities at 405 nm are means of two rabbits with four technical replicates each.
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Figure A.5

Lineage II strains

RM3109

RM2995

RM2707

ST33007

RM3102

RM3020

RM3000

ST33014

RM3171

RM3170

RM3030

ST33077

21 days post
immunization of 1897

Lineage I Strains

Reactivity of ST33077_1897-specific rabbit immune serum against representative
strains in lineages III, I, and II.

Antibody response was determined by ELISA using plates coated with whole cell lysate of each
strain shown using rabbit sera collected 21 days post-injection with ST33077_1897 purified
protein. Optical densities at 405 nm are means of two rabbits with four technical replicates each.
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Figure A.6

Lineage II strains

RM3109

RM2995

RM2707

ST33007

PRE-INJECTION OF 1129
POST INJECTION OF 1129

RM3102

RM3020

RM3000

ST33014

RM3171
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RM3030

4
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ST33077

OD 405 nm

ST33077_1129

Lineage I Strains

Reactivity of ST33077_1129-specific rabbit immune serum against representative
strains in lineages III, I, and II.

Antibody response was determined by ELISA using plates coated with whole cell lysate of each
strain shown using rabbit sera collected 21 days post-injection with ST33077_1129 purified
protein. Optical densities at 405 nm are means of two rabbits with four technical replicates each.
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Lineage III strains

Figure A.7

Lineage II strains

RM3109

RM2995

RM2707

ST33007

RM3102

RM3020

RM3000

ST33014

RM3171

RM3170

*

RM3030

3
2.5
2
1.5
1
0.5
0

ST33077

OD 405 nm

ST33077_ 1926

Lineage I Strains

Difference in mean serum reactivity between pre-injection serum and
ST33077_1926-specific serum. Optical densities at 405 nm are the means of two
rabbit’s post immunization sera titer after subtracting of pre-injection serum titer
from post-injection titer. Four technical replicates for each rabbit were used and
tested against 12 L. monocytogenes strains. The result shows significantly higher
antibody titer in comparing means of lineage III strains to the mean of lineage I
and II (P <0.0001). The result also shows significantly higher antibody titer in
comparing each strain of lineage III separately to the mean of lineage I and II.
Significant differences in reactivity to lineage III strains are indicated by asterisks
(P < 0.05)
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Figure A.8

Lineage II strains

RM3109

RM2995

RM2707

ST33007

RM3102

RM3020

RM3000

ST33014

RM3171

RM3170

RM3030

ST33077

0

Lineage I Strains

Difference in mean serum reactivity between pre-injection serum and
ST33077_2770-specific serum. Optical densities at 405 nm are the means of two
rabbit’s post immunization sera titer after subtracting of pre-injection serum titer
from post-injection titer. Four technical replicates for each rabbit were used and
tested against 12 L. monocytogenes strains. The result shows significantly higher
antibody titer in comparing means of lineage III strains to the mean of lineage I
and II (P <0.0018). The result also shows significantly higher antibody titer in
comparing each strain of lineage III separately to the mean of lineage I and II.
Significant differences in reactivity to lineage III strains are indicated by asterisks
(P <0.05)
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Figure A.9

Lineage II strains

RM3109
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ST33007

RM3102

RM3020

RM3000

ST33014

RM3171

RM3170

RM3030

ST33077

0

Lineage I Strains

Difference in mean serum reactivity between pre-injection serum and
ST33077_1897-specific serum. Optical densities at 405 nm are the means of two
rabbit’s post immunization sera titer after subtracting of pre injection serum titer
from post injection titer. Four technical replicates for each rabbit were used and
tested against 12 L. monocytogenes strains. The result shows no significant
difference between the mean of lineage III compared to lineage I and II.
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Figure A.10 Difference in mean serum reactivity between pre-injection serum and
ST33077_1129-specific serum. Optical densities at 405 nm are the means of two
rabbit’s post immunization sera titer after subtracting of pre injection serum titer
from post injection titer. Four technical replicates for each rabbit were used and
tested against 12 L. monocytogenes strains. The result shows no significant
difference between the mean of lineage III compared to lineage I and II.
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Figure A.11 Automated capillary Western blot gel-like image of ST33077_1926.
The predicted molecular weight of ST33077_1926 is 33.62 kDa. Lane 1: Manfacturer molecular
weight standard; lane 2: Manufacturer Hela control; lane 3: Immune serum with no recombinant
protein ; lanes 4-7: 5 µg ST33077_1926 with varying dilutions of immune serum.
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Figure A.12 Automated capillary Western blot gel-like image of ST33077_2770. The predicted
molecular weight of ST33077_2770 is 20.9 kDa. Lane 1: Manufacturer molecular
weight standard; lane 2: manufacturer Hela control; lane 3: immune serum with no
recombinant protein; lanes 4-10: 2.5 µg ST33077_2770 with varying dilutions of
immune serum.
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